These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 29242552)

  • 1. A general pharmacodynamic interaction model identifies perpetrators and victims in drug interactions.
    Wicha SG; Chen C; Clewe O; Simonsson USH
    Nat Commun; 2017 Dec; 8(1):2129. PubMed ID: 29242552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparisons of Analysis Methods for Assessment of Pharmacodynamic Interactions Including Design Recommendations.
    Chen C; Wicha SG; Nordgren R; Simonsson USH
    AAPS J; 2018 Jun; 20(4):77. PubMed ID: 29931471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complex interactions of lovastatin with 10 chemotherapeutic drugs: a rigorous evaluation of synergism and antagonism.
    Khandelwal Gilman KA; Han S; Won YW; Putnam CW
    BMC Cancer; 2021 Apr; 21(1):356. PubMed ID: 33823841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards a mechanism-based analysis of pharmacodynamic drug-drug interactions in vivo.
    Jonker DM; Visser SA; van der Graaf PH; Voskuyl RA; Danhof M
    Pharmacol Ther; 2005 Apr; 106(1):1-18. PubMed ID: 15781119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concentration-dependent synergy and antagonism within a triple antifungal drug combination against Aspergillus species: analysis by a new response surface model.
    Meletiadis J; Stergiopoulou T; O'Shaughnessy EM; Peter J; Walsh TJ
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2053-64. PubMed ID: 17387150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing Pharmacodynamic Interactions in Mice Using the Multistate Tuberculosis Pharmacometric and General Pharmacodynamic Interaction Models.
    Chen C; Wicha SG; de Knegt GJ; Ortega F; Alameda L; Sousa V; de Steenwinkel JEM; Simonsson USH
    CPT Pharmacometrics Syst Pharmacol; 2017 Nov; 6(11):787-797. PubMed ID: 28657202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction index and different methods for determining drug interaction in combination therapy.
    Lee JJ; Kong M; Ayers GD; Lotan R
    J Biopharm Stat; 2007; 17(3):461-80. PubMed ID: 17479394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The concentration-dependent nature of in vitro amphotericin B-itraconazole interaction against Aspergillus fumigatus: isobolographic and response surface analysis of complex pharmacodynamic interactions.
    Meletiadis J; te Dorsthorst DT; Verweij PE
    Int J Antimicrob Agents; 2006 Nov; 28(5):439-49. PubMed ID: 17055706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A generalized response surface model with varying relative potency for assessing drug interaction.
    Kong M; Lee JJ
    Biometrics; 2006 Dec; 62(4):986-95. PubMed ID: 17156272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic combinations of anticonvulsant agents: what is the evidence from animal experiments?
    Jonker DM; Voskuyl RA; Danhof M
    Epilepsia; 2007 Mar; 48(3):412-34. PubMed ID: 17346245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel approach to characterization of combined pharmacodynamic effects of antimicrobial agents.
    Tam VH; Schilling AN; Lewis RE; Melnick DA; Boucher AN
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4315-21. PubMed ID: 15504858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flexible interaction model for complex interactions of multiple anesthetics.
    Fidler M; Kern SE
    Anesthesiology; 2006 Aug; 105(2):286-96. PubMed ID: 16871062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacodynamic interaction model and its clinical application].
    Tang M; Zhang W
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2009 Jun; 26(3):692-6. PubMed ID: 19634700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies.
    Chou TC
    Pharmacol Rev; 2006 Sep; 58(3):621-81. PubMed ID: 16968952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of drug interactions relevant to pharmacodynamic indirect response models.
    Earp J; Krzyzanski W; Chakraborty A; Zamacona MK; Jusko WJ
    J Pharmacokinet Pharmacodyn; 2004 Oct; 31(5):345-80. PubMed ID: 15669772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of non-linear combination effect terms for drug-drug interactions.
    Koch G; Schropp J; Jusko WJ
    J Pharmacokinet Pharmacodyn; 2016 Oct; 43(5):461-79. PubMed ID: 27638639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of in vitro synergy between vertilmicin and ceftazidime against Pseudomonas aeruginosa using a semi-mechanistic pharmacokinetic/pharmacodynamic model.
    Zhuang L; Sy SK; Xia H; Singh RP; Mulder MB; Liu C; Derendorf H
    Int J Antimicrob Agents; 2015 Feb; 45(2):151-60. PubMed ID: 25465523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic-pharmacodynamic modeling of the antihypertensive interaction between azilsartan medoxomil and chlorthalidone in spontaneously hypertensive rats.
    Kumar Puttrevu S; Ramakrishna R; Bhateria M; Jain M; Hanif K; Bhatta RS
    Naunyn Schmiedebergs Arch Pharmacol; 2017 May; 390(5):457-470. PubMed ID: 28190245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simulations of Cytochrome P450 3A4-Mediated Drug-Drug Interactions by Simple Two-Compartment Model-Assisted Static Method.
    Iga K; Kiriyama A
    J Pharm Sci; 2017 May; 106(5):1426-1438. PubMed ID: 28089686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergent Gene Expression Responses to Drug Combinations Predict Higher-Order Drug Interactions.
    Lukačišin M; Bollenbach T
    Cell Syst; 2019 Nov; 9(5):423-433.e3. PubMed ID: 31734160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.